These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1093 related items for PubMed ID: 11950011

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice.
    Hu N, Long H, Zhao M, Yin H, Lu Q.
    Scand J Rheumatol; 2009; 38(6):464-71. PubMed ID: 19922023
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The in vivo induction of lymphocyte apoptosis in MRL-lpr/lpr mice treated with FTY720.
    Suzuki S, Li XK, Shinomiya T, Enosawa S, Amemiya H, Amari M, Naoe S.
    Clin Exp Immunol; 1997 Jan; 107(1):103-11. PubMed ID: 9010264
    [Abstract] [Full Text] [Related]

  • 26. Abrogation of skin disease in LUPUS-prone MRL/FASlpr mice by means of a novel tylophorine analog.
    Choi JY, Gao W, Odegard J, Shiah HS, Kashgarian M, McNiff JM, Baker DC, Cheng YC, Craft J.
    Arthritis Rheum; 2006 Oct; 54(10):3277-83. PubMed ID: 17009262
    [Abstract] [Full Text] [Related]

  • 27. Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus.
    McMurray RW, Elbourne KB, Lagoo A, Lal S.
    J Rheumatol; 1998 Dec; 25(12):2364-70. PubMed ID: 9858431
    [Abstract] [Full Text] [Related]

  • 28. B cell apoptosis accelerates the onset of murine lupus.
    Trébéden-Nègre H, Weill B, Fournier C, Batteux F.
    Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
    [Abstract] [Full Text] [Related]

  • 29. MRL/Mp CD4+,CD25- T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus.
    Monk CR, Spachidou M, Rovis F, Leung E, Botto M, Lechler RI, Garden OA.
    Arthritis Rheum; 2005 Apr; 52(4):1180-4. PubMed ID: 15818683
    [Abstract] [Full Text] [Related]

  • 30. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.
    Parietti V, Monneaux F, Décossas M, Muller S.
    Arthritis Rheum; 2008 Jun; 58(6):1751-61. PubMed ID: 18512811
    [Abstract] [Full Text] [Related]

  • 31. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
    Anders HJ, Vielhauer V, Eis V, Linde Y, Kretzler M, Perez de Lema G, Strutz F, Bauer S, Rutz M, Wagner H, Gröne HJ, Schlöndorff D.
    FASEB J; 2004 Mar; 18(3):534-6. PubMed ID: 14734643
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of experimental autoimmune uveitis in mice treated with FTY720.
    Commodaro AG, Peron JP, Lopes CT, Arslanian C, Belfort R, Rizzo LV, Bueno V.
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2568-74. PubMed ID: 20019358
    [Abstract] [Full Text] [Related]

  • 33. IL-12-encoding plasmid has a beneficial effect on spontaneous autoimmune disease in MRL/MP-lpr/lpr mice.
    Hagiwara E, Okubo T, Aoki I, Ohno S, Tsuji T, Ihata A, Ueda A, Shirai A, Okuda K, Miyazaki J, Ishigatsubo Y.
    Cytokine; 2000 Jul; 12(7):1035-41. PubMed ID: 10880249
    [Abstract] [Full Text] [Related]

  • 34. Anti-Ccl2 Spiegelmer permits 75% dose reduction of cyclophosphamide to control diffuse proliferative lupus nephritis and pneumonitis in MRL-Fas(lpr) mice.
    Kulkarni O, Eulberg D, Selve N, Zöllner S, Allam R, Pawar RD, Pfeiffer S, Segerer S, Klussmann S, Anders HJ.
    J Pharmacol Exp Ther; 2009 Feb; 328(2):371-7. PubMed ID: 18997060
    [Abstract] [Full Text] [Related]

  • 35. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs.
    Hofmann M, Brinkmann V, Zerwes HG.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):1902-10. PubMed ID: 17161343
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Suppression of antigen-specific interleukin 2 production in the MRL/MpJ-lpr/lpr mouse.
    Naides SJ.
    J Immunol; 1986 Jun 01; 136(11):4113-21. PubMed ID: 2422273
    [Abstract] [Full Text] [Related]

  • 38. The ethyl acetate extract of alfalfa sprout ameliorates disease severity of autoimmune-prone MRL-lpr/lpr mice.
    Hong YH, Huang CJ, Wang SC, Lin BF.
    Lupus; 2009 Mar 01; 18(3):206-15. PubMed ID: 19213858
    [Abstract] [Full Text] [Related]

  • 39. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
    Matsumoto K, Watanabe N, Akikusa B, Kurasawa K, Matsumura R, Saito Y, Iwamoto I, Saito T.
    Arthritis Rheum; 2003 Feb 01; 48(2):486-94. PubMed ID: 12571859
    [Abstract] [Full Text] [Related]

  • 40. Fate of immune complexes, glomerulonephritis, and cell-mediated vasculitis in lupus-prone MRL/Mp lpr/lpr mice.
    Cruse JM, Lewis RE, Dilioglou S.
    Exp Mol Pathol; 2000 Dec 01; 69(3):211-22. PubMed ID: 11115362
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 55.